Treatment of acquired perforating dermatosis with narrowband ultraviolet B.
Acquired perforating dermatosis is difficult to treat. We describe effective therapy of acquired perforating dermatosis with narrowband UVB in 5 patients. Phototherapy was given 2 or 3 times weekly. The dose was started at 400 mJ/cm(2) and increased to a maximum of 1500 mJ/cm(2). All lesions disappeared completely after 10 to 15 exposures without adverse effects. Two patients with diabetes mellitus but without chronic renal failure experienced no recurrence until 5 and 10 months after stopping the phototherapy. One patient undergoing hemodialysis for chronic renal failure experienced a recurrence of pruritus and small papules after 1 month. Two patients undergoing hemodialysis showed no recurrence during narrowband UVB maintenance therapy until 7 and 8 months.
Ohe
Shuichi
S
Department of Dermatology, Kansai Medical University, Osaka, Japan.
Danno
Kiichiro
K
Sasaki
Hiroko
H
Isei
Taiki
T
Okamoto
Hiroyuki
H
Horio
Takeshi
T
D000368:Aged; D048909:Diabetes Complications; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D012871:Skin Diseases / Q000532:radiotherapy*; D014467:Ultraviolet Therapy / Q000379:methods